BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+7.76%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$572M
AUM Growth
+$572M
Cap. Flow
-$6.13M
Cap. Flow %
-1.07%
Top 10 Hldgs %
86.44%
Holding
30
New
4
Increased
5
Reduced
6
Closed
4

Top Buys

1
OMED
OncoMed Pharmaceuticals, Inc.
OMED
$20.6M
2
IRWD icon
Ironwood Pharmaceuticals
IRWD
$19.5M
3
CCXI
ChemoCentryx, Inc.
CCXI
$14M
4
FPRX
Five Prime Therapeutics, Inc.
FPRX
$7.74M
5
XNCR icon
Xencor
XNCR
$7.5M

Top Sells

1
LGND icon
Ligand Pharmaceuticals
LGND
$27.7M
2
EXEL icon
Exelixis
EXEL
$14.6M
3
ARRY
Array Biopharma Inc
ARRY
$10.9M
4
AVNR
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$10.3M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$6.84M

Sector Composition

1 Healthcare 76.74%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LGND icon
1
Ligand Pharmaceuticals
LGND
$3.15B
$138M 24.17% 2,626,160 -527,505 -17% -$27.7M
IRWD icon
2
Ironwood Pharmaceuticals
IRWD
$214M
$111M 19.45% 9,575,649 +1,679,588 +21% +$19.5M
CCXI
3
DELISTED
ChemoCentryx, Inc.
CCXI
$45.1M 7.9% 7,796,516 +2,418,900 +45% +$14M
ARRY
4
DELISTED
Array Biopharma Inc
ARRY
$37.8M 6.62% 7,553,089 -2,166,500 -22% -$10.9M
OMED
5
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$32.2M 5.63% 1,090,478 +698,678 +178% +$20.6M
GYRE icon
6
Gyre Therapeutics
GYRE
$703M
$25.6M 4.48% 6,171,669 – –
RIGL icon
7
Rigel Pharmaceuticals
RIGL
$697M
$22.6M 3.96% 7,943,215 -1,787,482 -18% -$5.09M
CASC
8
DELISTED
Cascadian Therapeutics, Inc.
CASC
$15.8M 2.77% 9,001,778 +129,000 +1% +$227K
CYTK icon
9
Cytokinetics
CYTK
$4.23B
$15.4M 2.69% 2,368,905 +650,000 +38% +$4.23M
QLTI
10
DELISTED
QLT Inc
QLTI
$13.2M 2.31% 2,370,263 – –
RCPT
11
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$9.18M 1.61% 316,692 -3,308 -1% -$95.9K
TBRA
12
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$7.91M 1.38% 1,659,091 – –
FPRX
13
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$7.74M 1.35% +461,000 New +$7.74M
XNCR icon
14
Xencor
XNCR
$580M
$7.5M 1.31% +820,000 New +$7.5M
ARQL
15
DELISTED
Arqule Inc
ARQL
$6.07M 1.06% 2,824,387 -110,800 -4% -$238K
PTN
16
DELISTED
Palatin Technologies
PTN
$3.82M 0.67% 5,200,000 – –
BIND
17
DELISTED
BIND THERAPEUTICS INC
BIND
$2.26M 0.4% +150,000 New +$2.26M
MRTX
18
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.23M 0.39% 134,317 -411,055 -75% -$6.84M
SPHS
19
DELISTED
Sophiris Bio, Inc.
SPHS
$2.22M 0.39% 600,000 – –
RGLS
20
DELISTED
Regulus Therapeutics
RGLS
$1.73M 0.3% 233,689 – –
KIN
21
DELISTED
Kindred Biosciences, Inc.
KIN
$577K 0.1% +51,788 New +$577K
PRTK
22
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$504K 0.09% 150,000 – –
AGIO icon
23
Agios Pharmaceuticals
AGIO
$2.19B
$47K 0.01% 196,996 – –
ANTH
24
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$17K ﹤0.01% 559,624 – –
EXEL icon
25
Exelixis
EXEL
$10.1B
– – -2,502,256 Closed -$14.6M
1
2